Skip to main content
Clinical Trials/ACTRN12614001024639
ACTRN12614001024639
Completed
Phase 2

A randomised controlled study, investigating the epigenetic changes in expression of inflammatory genes through associated blood biomarkers, using curcumin, in older healthy and mild cognitive impairment participants

McCusker Alzheimers Research Foundation0 sites48 target enrollmentSeptember 24, 2014

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
McCusker Alzheimers Research Foundation
Enrollment
48
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 24, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
McCusker Alzheimers Research Foundation

Eligibility Criteria

Inclusion Criteria

  • Arm 1: Healthy Volunteers
  • 1\. Age 65\-90 years, with general good health.
  • 2\. No significant history of cerebral vascular disease, such as
  • a stroke, within the last 5 years.
  • 3\. Living in independent living units, or similar accommodation
  • 4\. English speaker, with adequate vision and hearing to enable testing
  • 5\. Normal general cognitive function, as determined by a Montreal Cognitive Assessment (MoCA) score, greater than or equal to 26\.
  • 6\. No change in ADLs as determined by a clinical interview, and confirmed by an informant using the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)
  • Arm 2: Mild Cognitive Impairment Volunteers
  • 1\-4, as listed above

Exclusion Criteria

  • 1\. Diagnosis of dementia based on the revised NIA/AA criteria
  • 2\. MoCA score of less than or equal to 17
  • 3\. Prior history of stroke within the last 5 years
  • 4\. Significant psychiatric disorder, including schizophrenia or
  • bipolar disorder
  • 5\. History of alcohol or drug abuse / dependence within 2
  • years of screening
  • 6\. Uncontrolled, clinical or subclinical depression as evidenced
  • by a score of greater or equal to 4 on the Geriatric
  • Depression scale.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
ifestyle Intervention in Independent Living Aged CareInfluence of diet change on cognition, mood and wellnessInfluence of diet change on blood biomarkers and cardiovascular healthInfluence of exercise change on cognition, mood and wellnessInfluence of exercise change on blood biomarkers and cardiovascular healthDiet and Nutrition - Other diet and nutrition disordersCardiovascular - Other cardiovascular diseasesMental Health - Studies of normal psychology, cognitive function and behaviour
ACTRN12614001133628Swinburne University of Technology208
Not yet recruiting
Not Applicable
A randomised controlled trial investigating carbon dioxide insufflation of the pericardial field as a neuroprotective strategy in open chamber cardiac surgery.
ACTRN12609000844246Department of Cardiothoracic Surgery140
Completed
Not Applicable
Addition of low dose primaquine to artemether-lumefantrine for the treatment of uncomplicated malariaMalaria
PACTR201611001859416niversity of Cape Town140
Completed
Not Applicable
A randomised controlled trial to investigate the effect of regular moderate intensity exercise on plasma fibrinogen in people with type two diabetes: a pilot studyType two diabetesNutritional, Metabolic, EndocrineNon-insulin-dependent diabetes mellitus
ISRCTN98564438Department of Health80
Completed
Not Applicable
A clinical trial to investigate the effect of psychological support for women called back for assessment following breast cancer screening: The TLC studyDepression and anxiety in women recalled for assessment following an abnormality on breast screeningMental and Behavioural DisordersDepressive episode
ISRCTN89206644Breast Test Wales300